chartexchange

Phio Pharmaceuticals to Present at the National Investment Banking Association (NIBA) 153rd Conference

Newsfile | Oct 5, 2026 7:00 AM EDT

King of Prussia, Pennsylvania--(Newsfile Corp. - October 5, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company developing cancer therapeutics based on its proprietary INTASYL® siRNA gene-silencing platform, today announced that it has accepted the invitation to present at the National Investment Banking Association's (NIBA) 153rd Conference on October 6-7, 2026, in Fort Lauderdale, Florida.Robert Bitterman, President and Chief Executive Officer, will...

Read original article